Cargando…
Enhanced immunogenicity of a positively supercharged archaeon thioredoxin scaffold as a cell-penetrating antigen carrier for peptide vaccines
Polycationic resurfaced proteins hold great promise as cell-penetrating bioreagents but their use as carriers for the intracellular delivery of peptide immuno-epitopes has not thus far been explored. Here, we report on the construction and functional characterization of a positively supercharged der...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405434/ https://www.ncbi.nlm.nih.gov/pubmed/36032169 http://dx.doi.org/10.3389/fimmu.2022.958123 |
_version_ | 1784773880121917440 |
---|---|
author | Cavazzini, Davide Spagnoli, Gloria Mariz, Filipe Colaco Reggiani, Filippo Maggi, Stefano Franceschi, Valentina Donofrio, Gaetano Müller, Martin Bolchi, Angelo Ottonello, Simone |
author_facet | Cavazzini, Davide Spagnoli, Gloria Mariz, Filipe Colaco Reggiani, Filippo Maggi, Stefano Franceschi, Valentina Donofrio, Gaetano Müller, Martin Bolchi, Angelo Ottonello, Simone |
author_sort | Cavazzini, Davide |
collection | PubMed |
description | Polycationic resurfaced proteins hold great promise as cell-penetrating bioreagents but their use as carriers for the intracellular delivery of peptide immuno-epitopes has not thus far been explored. Here, we report on the construction and functional characterization of a positively supercharged derivative of Pyrococcus furiosus thioredoxin (PfTrx), a thermally hyperstable protein we have previously validated as a peptide epitope display and immunogenicity enhancing scaffold. Genetic conversion of 13 selected amino acids to lysine residues conferred to PfTrx a net charge of +21 (starting from the -1 charge of the wild-type protein), along with the ability to bind nucleic acids. In its unfused form, +21 PfTrx was readily internalized by HeLa cells and displayed a predominantly cytosolic localization. A different intracellular distribution was observed for a +21 PfTrx-eGFP fusion protein, which although still capable of cell penetration was predominantly localized within endosomes. A mixed cytosolic/endosomal partitioning was observed for a +21 PfTrx derivative harboring three tandemly repeated copies of a previously validated HPV16-L2 (aa 20-38) B-cell epitope grafted to the display site of thioredoxin. Compared to its wild-type counterpart, the positively supercharged antigen induced a faster immune response and displayed an overall superior immunogenicity, including a substantial degree of self-adjuvancy. Altogether, the present data point to +21 PfTrx as a promising novel carrier for intracellular antigen delivery and the construction of potentiated recombinant subunit vaccines. |
format | Online Article Text |
id | pubmed-9405434 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-94054342022-08-26 Enhanced immunogenicity of a positively supercharged archaeon thioredoxin scaffold as a cell-penetrating antigen carrier for peptide vaccines Cavazzini, Davide Spagnoli, Gloria Mariz, Filipe Colaco Reggiani, Filippo Maggi, Stefano Franceschi, Valentina Donofrio, Gaetano Müller, Martin Bolchi, Angelo Ottonello, Simone Front Immunol Immunology Polycationic resurfaced proteins hold great promise as cell-penetrating bioreagents but their use as carriers for the intracellular delivery of peptide immuno-epitopes has not thus far been explored. Here, we report on the construction and functional characterization of a positively supercharged derivative of Pyrococcus furiosus thioredoxin (PfTrx), a thermally hyperstable protein we have previously validated as a peptide epitope display and immunogenicity enhancing scaffold. Genetic conversion of 13 selected amino acids to lysine residues conferred to PfTrx a net charge of +21 (starting from the -1 charge of the wild-type protein), along with the ability to bind nucleic acids. In its unfused form, +21 PfTrx was readily internalized by HeLa cells and displayed a predominantly cytosolic localization. A different intracellular distribution was observed for a +21 PfTrx-eGFP fusion protein, which although still capable of cell penetration was predominantly localized within endosomes. A mixed cytosolic/endosomal partitioning was observed for a +21 PfTrx derivative harboring three tandemly repeated copies of a previously validated HPV16-L2 (aa 20-38) B-cell epitope grafted to the display site of thioredoxin. Compared to its wild-type counterpart, the positively supercharged antigen induced a faster immune response and displayed an overall superior immunogenicity, including a substantial degree of self-adjuvancy. Altogether, the present data point to +21 PfTrx as a promising novel carrier for intracellular antigen delivery and the construction of potentiated recombinant subunit vaccines. Frontiers Media S.A. 2022-08-09 /pmc/articles/PMC9405434/ /pubmed/36032169 http://dx.doi.org/10.3389/fimmu.2022.958123 Text en Copyright © 2022 Cavazzini, Spagnoli, Mariz, Reggiani, Maggi, Franceschi, Donofrio, Müller, Bolchi and Ottonello https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Immunology Cavazzini, Davide Spagnoli, Gloria Mariz, Filipe Colaco Reggiani, Filippo Maggi, Stefano Franceschi, Valentina Donofrio, Gaetano Müller, Martin Bolchi, Angelo Ottonello, Simone Enhanced immunogenicity of a positively supercharged archaeon thioredoxin scaffold as a cell-penetrating antigen carrier for peptide vaccines |
title | Enhanced immunogenicity of a positively supercharged archaeon thioredoxin scaffold as a cell-penetrating antigen carrier for peptide vaccines |
title_full | Enhanced immunogenicity of a positively supercharged archaeon thioredoxin scaffold as a cell-penetrating antigen carrier for peptide vaccines |
title_fullStr | Enhanced immunogenicity of a positively supercharged archaeon thioredoxin scaffold as a cell-penetrating antigen carrier for peptide vaccines |
title_full_unstemmed | Enhanced immunogenicity of a positively supercharged archaeon thioredoxin scaffold as a cell-penetrating antigen carrier for peptide vaccines |
title_short | Enhanced immunogenicity of a positively supercharged archaeon thioredoxin scaffold as a cell-penetrating antigen carrier for peptide vaccines |
title_sort | enhanced immunogenicity of a positively supercharged archaeon thioredoxin scaffold as a cell-penetrating antigen carrier for peptide vaccines |
topic | Immunology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9405434/ https://www.ncbi.nlm.nih.gov/pubmed/36032169 http://dx.doi.org/10.3389/fimmu.2022.958123 |
work_keys_str_mv | AT cavazzinidavide enhancedimmunogenicityofapositivelysuperchargedarchaeonthioredoxinscaffoldasacellpenetratingantigencarrierforpeptidevaccines AT spagnoligloria enhancedimmunogenicityofapositivelysuperchargedarchaeonthioredoxinscaffoldasacellpenetratingantigencarrierforpeptidevaccines AT marizfilipecolaco enhancedimmunogenicityofapositivelysuperchargedarchaeonthioredoxinscaffoldasacellpenetratingantigencarrierforpeptidevaccines AT reggianifilippo enhancedimmunogenicityofapositivelysuperchargedarchaeonthioredoxinscaffoldasacellpenetratingantigencarrierforpeptidevaccines AT maggistefano enhancedimmunogenicityofapositivelysuperchargedarchaeonthioredoxinscaffoldasacellpenetratingantigencarrierforpeptidevaccines AT franceschivalentina enhancedimmunogenicityofapositivelysuperchargedarchaeonthioredoxinscaffoldasacellpenetratingantigencarrierforpeptidevaccines AT donofriogaetano enhancedimmunogenicityofapositivelysuperchargedarchaeonthioredoxinscaffoldasacellpenetratingantigencarrierforpeptidevaccines AT mullermartin enhancedimmunogenicityofapositivelysuperchargedarchaeonthioredoxinscaffoldasacellpenetratingantigencarrierforpeptidevaccines AT bolchiangelo enhancedimmunogenicityofapositivelysuperchargedarchaeonthioredoxinscaffoldasacellpenetratingantigencarrierforpeptidevaccines AT ottonellosimone enhancedimmunogenicityofapositivelysuperchargedarchaeonthioredoxinscaffoldasacellpenetratingantigencarrierforpeptidevaccines |